Correlation Between Capricor Therapeutics and Aileron Therapeutics
Can any of the company-specific risk be diversified away by investing in both Capricor Therapeutics and Aileron Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capricor Therapeutics and Aileron Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Capricor Therapeutics and Aileron Therapeutics, you can compare the effects of market volatilities on Capricor Therapeutics and Aileron Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capricor Therapeutics with a short position of Aileron Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capricor Therapeutics and Aileron Therapeutics.
Diversification Opportunities for Capricor Therapeutics and Aileron Therapeutics
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Capricor and Aileron is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Capricor Therapeutics and Aileron Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aileron Therapeutics and Capricor Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capricor Therapeutics are associated (or correlated) with Aileron Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aileron Therapeutics has no effect on the direction of Capricor Therapeutics i.e., Capricor Therapeutics and Aileron Therapeutics go up and down completely randomly.
Pair Corralation between Capricor Therapeutics and Aileron Therapeutics
Given the investment horizon of 90 days Capricor Therapeutics is expected to generate 0.69 times more return on investment than Aileron Therapeutics. However, Capricor Therapeutics is 1.44 times less risky than Aileron Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Aileron Therapeutics is currently generating about 0.04 per unit of risk. If you would invest 404.00 in Capricor Therapeutics on September 3, 2024 and sell it today you would earn a total of 1,497 from holding Capricor Therapeutics or generate 370.54% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Capricor Therapeutics vs. Aileron Therapeutics
Performance |
Timeline |
Capricor Therapeutics |
Aileron Therapeutics |
Capricor Therapeutics and Aileron Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Capricor Therapeutics and Aileron Therapeutics
The main advantage of trading using opposite Capricor Therapeutics and Aileron Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capricor Therapeutics position performs unexpectedly, Aileron Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aileron Therapeutics will offset losses from the drop in Aileron Therapeutics' long position.Capricor Therapeutics vs. Bio Path Holdings | Capricor Therapeutics vs. NextCure | Capricor Therapeutics vs. Pulmatrix | Capricor Therapeutics vs. Akari Therapeutics PLC |
Aileron Therapeutics vs. Bio Path Holdings | Aileron Therapeutics vs. Benitec Biopharma Ltd | Aileron Therapeutics vs. Artelo Biosciences | Aileron Therapeutics vs. Histogen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |